Most cited papers in Vascular Malformations and Hemangiomas
What are the most cited papers in Vascular Malformations and Hemangiomas?
The most cited paper in Vascular Malformations and Hemangiomas is "Lymphangiogenesis: Molecular Mechanisms and Future Promise" (Tuomas Tammela, Kari K. Alitalo, 2010), with 1,469 citations. Next come "Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies" (1,425) and "Recurrent BRAF mutations in Langerhans cell histiocytosis" (1,255).
Showing 50 of 100 papers. Every paper with more than 393 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Lymphangiogenesis: Molecular Mechanisms and Future Promise Tuomas Tammela, Kari K. Alitalo · Cell | Feb 2010 | 1,469 |
| 2 | Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies Michel Wassef, Francine Blei, Denise M. Adams et al. · PEDIATRICS | 10 Jun 2015 | 1,425 |
| 3 | Recurrent BRAF mutations in Langerhans cell histiocytosis Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara A. Degar et al. · Blood | 2 Jun 2010 | 1,255 |
| 4 | Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ Matthew D. Shirley, Hao Tang, Carol J. Gallione et al. · New England Journal of Medicine | 8 May 2013 | 1,116 |
| 5 | Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries Silvana Breiteneder-Geleff, Afschin Soleiman, Heinrich Kowalski et al. · American Journal Of Pathology | Feb 1999 | 1,099 |
| 6 | Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy R. Alan B. Ezekowitz, John Butler Mulliken, Judah Folkman · New England Journal of Medicine | 28 May 1992 | 1,079 |
| 7 | International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease Arezou Khosroshahi et al. · Arthritis & Rheumatology | 25 Mar 2015 | 1,071 |
| 8 | VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment Claus Cursiefen, Lu Chen, Leonardo P. Borges et al. · Journal of Clinical Investigation | Apr 2004 | 1,033 |
| 9 | Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients Giovanni Stallone, Antonio Schena, Barbara Infante et al. · New England Journal of Medicine | 30 Mar 2005 | 992 |
| 10 | Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis Stefano J. Mandriota, Lotta Jussila, Michael Jeltsch et al. · The EMBO Journal | 15 Feb 2001 | 989 |
| 11 | A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome Marjorie J. Lindhurst et al. · New England Journal of Medicine | 27 Jul 2011 | 896 |
| 12 | GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas Paula E. North, Milton Waner, Adam Mizeracki et al. · Human Pathology | 2000 | 861 |
| 13 | Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies Denise M. Adams et al. · PEDIATRICS | 18 Jan 2016 | 851 |
| 14 | Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation Eric Legius et al. · Genetics in Medicine | 4 Jun 2021 | 832 |
| 15 | A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma Christine Léauté-Labrèze et al. · New England Journal of Medicine | 18 Feb 2015 | 804 |
| 16 | Lymphangiogenesis and cancer metastasis Steven A. Stacker, Marc G. Achen, Lotta Jussila et al. · Nature reviews. Cancer | Aug 2002 | 801 |
| 17 | Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis SEBASTIAN FRIEDRICH SCHOPPMANN, Peter Birner, Johannes Stöckl et al. · American Journal Of Pathology | Sep 2002 | 797 |
| 18 | A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4) Carol J. Gallione, Gabriela M. Repetto, Eric Legius et al. · The Lancet | Mar 2004 | 761 |
| 19 | Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations Iiro Eerola, Laurence Myriam Boon, John Butler Mulliken et al. · The American Journal of Human Genetics | Dec 2003 | 760 |
| 20 | Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era Jamie McDonald, Whitney L. Wooderchak‐Donahue, Chad VanSant Webb et al. · Frontiers in Genetics | 26 Jan 2015 | 747 |
| 21 | Growth Characteristics of Infantile Hemangiomas: Implications for Management Linda C. Chang, Anita N. Haggstrom, Beth A. Drolet et al. · PEDIATRICS | Aug 2008 | 703 |
| 22 | Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years Riccardo Haupt, Milen Minkov, Itziar Astigarraga et al. · Pediatric Blood & Cancer | 25 Oct 2012 | 701 |
| 23 | T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema Vivien Schacht, María I. Ramirez, Young‐Kwon Hong et al. · The EMBO Journal | 9 Jul 2003 | 673 |
| 24 | Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems Fausto J. Rodríguez, Andrew L. Folpe, Caterina Giannini et al. · Acta Neuropathologica | 10 Feb 2012 | 672 |
| 25 | Germline mutations in PTEN are present in Bannayan-Zonana syndrome Debbie J. Marsh, Patricia L. M. Dahia, Zimu Zheng et al. · Nature Genetics | Aug 1997 | 657 |
| 26 | Cellular markers that distinguish the phases of hemangioma during infancy and childhood. Kenkichi Takahashi, John Butler Mulliken, Harry P. Kozakewich et al. · Journal of Clinical Investigation | Jun 1994 | 652 |
| 27 | Comparison of phenotypes of polycystic kidney disease types 1 and 2 Nick Hateboer, Marjan A. van Dijk, Nadja Bogdanova et al. · The Lancet | 1999 | 629 |
| 28 | Sirolimus for the treatment of complicated vascular anomalies in children Adrienne M. Hammill, MarySue Wentzel, Anita Kumari Gupta et al. · Pediatric Blood & Cancer | 28 Mar 2011 | 629 |
| 29 | Intestinal Intussusception: Etiology, Diagnosis, and Treatment Priscilla Marsicovetere, Srinivas Joga Ivatury, Brent C. White et al. · Clinics in Colon and Rectal Surgery | 22 Dec 2016 | 623 |
| 30 | Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and Treatment Anita N. Haggstrom, Beth A. Drolet, Eulàlia Baselga et al. · PEDIATRICS | Sep 2006 | 621 |
| 31 | Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas Harriette J. Kahn, Denis J Bailey, Alexander N. Marks · Modern Pathology | Apr 2002 | 602 |
| 32 | Congenital vascular lesions: Clinical application of a new classification Mary Collins Finn, Julie Glowacki, John Butler Mulliken · Journal of Pediatric Surgery | Dec 1983 | 601 |
| 33 | Oral pyogenic granuloma: a review Hamid Jafarzadeh, Majid Sanatkhani, Nooshin Mohtasham · Journal of Oral Science | 2006 | 600 |
| 34 | Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CA Valerie L. Luks et al. · The Journal of Pediatrics | 11 Feb 2015 | 597 |
| 35 | Targeted therapy in patients with PIK3CA-related overgrowth syndrome Quitterie Venot et al. · Nature | Jun 2018 | 596 |
| 36 | Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference Beth A. Drolet et al. · PEDIATRICS | 24 Dec 2012 | 596 |
| 37 | Familial gastrointestinal stromal tumours with germline mutation of the KIT gene Toshirou Nishida, Seiichi Hirota, Masahiko Taniguchi et al. · Nature Genetics | Aug 1998 | 595 |
| 38 | PIK3CA‐related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation Kim M. Keppler‐Noreuil, Jonathan J. Rios, Victoria Parker et al. · American Journal of Medical Genetics Part A | 31 Dec 2014 | 590 |
| 39 | Hemangiomas in Children Beth A. Drolet, Nancy B. Esterly, Ilona J. Frieden · New England Journal of Medicine | 15 Jul 1999 | 588 |
| 40 | Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease Gerd Walz, Klemens Budde, Marwan Mannaa et al. · New England Journal of Medicine | 26 Jun 2010 | 583 |
| 41 | Sox18 induces development of the lymphatic vasculature in mice Mathias François, Andréa Caprini, Brett M. Hosking et al. · Nature | 19 Oct 2008 | 577 |
| 42 | Propranolol for Severe Infantile Hemangiomas: Follow-Up Report Véronique Sans, Eric Dumas de la Roque, Jérôme Berge et al. · PEDIATRICS | 10 Aug 2009 | 572 |
| 43 | Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis Janice A. Nagy, Eliza Vasile, Dian Feng et al. · The Journal of Experimental Medicine | 2 Dec 2002 | 561 |
| 44 | Lethal genes surviving by mosaicism: A possible explanation for sporadic birth defects involving the skin Rudolf Happle · Journal of the American Academy of Dermatology | Apr 1987 | 560 |
| 45 | Severe Hypothyroidism Caused by Type 3 Iodothyronine Deiodinase in Infantile Hemangiomas Stephen A. Huang, Helen M. Tu, John W. Harney et al. · New England Journal of Medicine | 20 Jul 2000 | 559 |
| 46 | The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane Athar H. Chishti et al. · Trends in Biochemical Sciences | Aug 1998 | 553 |
| 47 | Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome Kyle C. Kurek, Valerie L. Luks, Ugur M. Ayturk et al. · The American Journal of Human Genetics | 31 May 2012 | 542 |
| 48 | Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia Marie E. Faughnan et al. · Annals of Internal Medicine | 7 Sep 2020 | 537 |
| 49 | Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature Christine Kilcline, Ilona J. Frieden · Pediatric Dermatology | Mar 2008 | 537 |
| 50 | Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action Corinna Storch, Peter H. Hoeger · British Journal of Dermatology | 8 May 2010 | 534 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.